BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3118717)

  • 1. Progestogen potency in oral contraceptive pills.
    Gillmer MD
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1048-52. PubMed ID: 3118717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New progestogens in oral contraceptives.
    Runnebaum B; Rabe T
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the new progestogens in combination oral contraceptives.
    Rebar RW; Zeserson K
    Contraception; 1991 Jul; 44(1):1-10. PubMed ID: 1832625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the potency of orally administered progestins in women.
    King RJ; Whitehead MI
    Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
    Chez RA
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1296-300. PubMed ID: 2524163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of progestins used in oral contraceptives.
    Dorflinger LJ
    Contraception; 1985 Jun; 31(6):557-70. PubMed ID: 3899503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.
    Hourihan HM; Sheppard BL; Bonnar J
    Contraception; 1986 Dec; 34(6):603-12. PubMed ID: 3103980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.